Robert Warshaw

Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.

Cooley advised Alentis Therapeutics, a clinical-stage biotechnology company developing treatments for Claudin-1 positive tumors and organ fibrosis, on its $181.4 million oversubscribed Series D financing round. Partners Brandon Fenn and Ryan Sansom led the Cooley team advising Alentis Therapeutics.

Cooley advised DEFCON AI, an insights company that’s building a next-generation modeling, simulation and analysis tool set for the modern military environment, on its $44 million in Seed financing.

Cooley advised Spring Health, the top global mental health solution for employers and health plans, on its $100 million Series E financing with a valuation of $3.3 billion.

Cooley advised Exor in its investment in Casavo’s $409.3 million Series D financing. Partner Stephane Levy led the Cooley team advising Exor, a private equity firm based in Amsterdam.